Skip to main content
    S

    Scinai Immunotherapeutics Ltd (SCNI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.40
    -0.04 (-9.50%)

    Market Cap: $1.05M

    Last updated: Nov 17, 2026 at 10:54 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    40%(8/20)
    Avg Surprise
    -27.10%

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-0.01xFCF Yield-8095.76%
    Profitability
    Profit Margin-80.10%Operating Margin-276.10%
    ROE-26.10%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage-26.59x
    Current Ratio1.23xQuick Ratio1.23x
    Trading Statistics
    Beta2.26Avg Volume115.80K
    52-Week High$13.0052-Week Low$0.39

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 63.3% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 25.2, below 30, the oversold line.

    Moving Averages

    SMA 10$0.46
    SMA 20$0.52
    SMA 50$1.09
    SMA 200$4.01
    EMA 10$0.47
    EMA 20$0.59
    EMA 50$1.09
    EMA 200$4.48

    MACD

    Line: -0.20Signal: -0.23Hist: 0.04

    ADX

    ADX: 18.9+DI: 14.8-DI: 24.1

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down100.0
    PSAR$0.55

    Bollinger Bands

    Upper Band$0.70
    Lower Band$0.34
    %B Position6745%(Upper)
    Band Width0.16

    RSI (14-Day)

    Oversold
    25.2

    Momentum Oscillators

    Stoch %K31.2
    Stoch %D37.6
    Williams %R-92.9
    ROC (10d)-15.2%
    Momentum-0.07
    CCI (20d)-114.8
    MFI (14d)52.7

    Volatility Measures

    ATR (14d)$0.13(33.2%)
    StdDev (20d)0.09
    Hist Vol85.5%(High)

    Volume Flow

    VWAP$0.41
    OBV285.1M
    AD Line918950158115.5B
    CMF (20d)-0.079

    Volume Metrics

    Avg Vol (20d)97.2K
    Vol Ratio1.0x
    VWMA (20d)$0.53

    Pivot Points

    R3$0.55
    R2$0.53
    R1$0.48
    Pivot Point$0.46
    S1$0.41
    S2$0.39
    S3$0.34

    Advanced Oscillators

    TSI-49.30
    Ultimate Osc36.7
    KST-551.93

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about SCNI

    News

    SCNI Valuation

    P/FCF
    -0.0x
    P/B
    0.0x
    All SCNI metrics

    SCNI Profitability: Margins, ROIC and FCF

    Scinai Immunotherapeutics (SCNI) has a gross margin of -142.2%, an operating margin of -276.1% and a net margin of -80.1%. It posts a -253.3% FCF margin.

    Gross margin
    -142.2%
    Operating margin
    -276.1%
    Net margin
    -80.1%
    ROE
    -26.1%
    FCF margin
    -253.3%
    FCF yield
    -8095.8%
    SCNI financial statements

    Scinai Immunotherapeutics Competitors

    The companies most similar to Scinai Immunotherapeutics (SCNI) include Scisparc, HCW Biologics and Silexion Therapeutics.

    Sector: Healthcare

    Companies most similar to Scinai Immunotherapeutics

    SCNI Bull Case vs Bear Case

    Bull case

    • SCNI grew quarterly revenue 572.0% year over year.

    Bear case

    • SCNI has a -80.1% net profit margin.
    • SCNI beat EPS estimates in 37.5% of its last 8 reported quarters.

    SCNI Earnings: Beat Rate

    Scinai Immunotherapeutics (SCNI) beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate (37.5%).

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -57.1%
    SCNI earnings history

    SCNI Earnings Call

    The latest SCNI earnings call transcript on file is labeled 2026Q2.

    Read the 2026Q2 transcript

    Updated Nov 12, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About SCNI

    Does SCNI pay dividends?

    Scinai Immunotherapeutics Ltd (SCNI) does not currently pay a regular dividend.

    What is SCNI's market cap?

    Scinai Immunotherapeutics Ltd (SCNI) has a market capitalization of $1.05M with a current stock price of $0.40.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.